Managing Director, RPM Ventures
Director, Stanford University Artificial Intelligence Laboratory
President and CEO, Acorda Therapeutics
Prof., Skaggs Inst. For Chemical Biology, Scripps Research Inst.
Partner, Nixon Peabody LLP
Founder and President, North Coast Biologics
Professor, J. David Gladstone Institute of Cardiovascular Disease
Professor of Chemistry, Scripps Research Institute
|
The FDA has approved a new test for the “superbug” methicillin-resistant Staphylococcus aureus (MRSA), according to the manufacturer, Waltham, MA-based Thermo Fisher Scientific (NYSE: TMO). The test, called Spectra MRSA, gives results within a day and integrates with routine lab systems to aid healthcare facilities’ efforts to screen their patients, the company said.
Boston · 6/14/12
8:30 am - 5:00 pm
Xconomy offers a number of ways to subscribe for free!
Subscribe Now
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.
